Hypoxia, one of the hallmarks of TME, stimulates the production of pro-angiogenic factors by tumor cells, particularly vascular endothelial growth factor (VEGF), resulting in the activation of the “angiogenic switch” [38]. This evidence concerns the gene VEGFA and neoplasm.